Caricamento...
Selective serotonin reuptake inhibitors and Alzheimer’s disease
Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are being prioritized. While the debate regarding whether depression is an etiological risk factor or a prodrome of AD rages on, a key determini...
Salvato in:
| Pubblicato in: | Neural Regen Res |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer - Medknow
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862425/ https://ncbi.nlm.nih.gov/pubmed/31535641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.264445 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|